Joseph Isangura
The Tanzanian government has reaffirmed that antiretroviral (ARV) drugs for people living with HIV/AIDS are available and provided free of charge across the country.
Government spokesperson and Secretary General of the Ministry of Information, Culture, Arts and Sports, Gerson Msigwa, emphasized that all patients can access treatment at public health facilities without any cost.
Speaking to reporters, Msigwa addressed concerns circulating among some patients about potential shortages of ARVs. He assured the public that the government is committed to maintaining a steady supply of the lifesaving medications. “ARVs are available, and every Tanzanian who needs them can access them safely and reliably,” Msigwa said.
Msigwa cautioned against storing ARVs at home due to fear of supply disruptions, explaining that improper storage could compromise the efficacy of the medicines. “Taking drugs home without following proper procedures can lead to deterioration, which will harm patients rather than help them,” he noted. He urged patients to follow health professionals’ guidance and collect their medications according to recommended schedules.
Also Read; Senegal Debates Asset Disclosure Law Amid Controversy
In addition to reaffirming the availability of ARVs, Msigwa highlighted the importance of continued HIV prevention measures, particularly among youth. He reminded citizens that while treatment is widely available, the virus remains a serious public health concern requiring ongoing vigilance and responsible behavior.
Some patients had previously expressed anxiety over the availability of medications following reports about changes in international aid. However, the government reiterated that all ARV medications remain free and accessible nationwide. Public health authorities continue to strengthen distribution channels to ensure equitable access for all citizens living with HIV.
Health experts note that Tanzania has made significant progress in expanding access to HIV treatment over the past decades, helping reduce HIV-related mortality and improving quality of life for thousands of patients. Continuous government oversight and support are seen as critical to maintaining these gains.
